TRAW
Price
$1.48
Change
-$0.24 (-13.95%)
Updated
Jun 5 closing price
Capitalization
8.43M
VTVT
Price
$16.67
Change
+$0.67 (+4.19%)
Updated
Jun 5, 12:57 PM (EDT)
Capitalization
43.63M
Interact to see
Advertisement

TRAW vs VTVT

Header iconTRAW vs VTVT Comparison
Open Charts TRAW vs VTVTBanner chart's image
Traws Pharma
Price$1.48
Change-$0.24 (-13.95%)
Volume$593.27K
Capitalization8.43M
vTv Therapeutics
Price$16.67
Change+$0.67 (+4.19%)
Volume$195
Capitalization43.63M
TRAW vs VTVT Comparison Chart
Loading...
TRAW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TRAW vs. VTVT commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TRAW is a Hold and VTVT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (TRAW: $1.51 vs. VTVT: $16.67)
Brand notoriety: TRAW and VTVT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: TRAW: 36% vs. VTVT: 9%
Market capitalization -- TRAW: $8.43M vs. VTVT: $43.63M
TRAW [@Biotechnology] is valued at $8.43M. VTVT’s [@Biotechnology] market capitalization is $43.63M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TRAW’s FA Score shows that 1 FA rating(s) are green whileVTVT’s FA Score has 0 green FA rating(s).

  • TRAW’s FA Score: 1 green, 4 red.
  • VTVT’s FA Score: 0 green, 5 red.
According to our system of comparison, TRAW is a better buy in the long-term than VTVT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TRAW’s TA Score shows that 3 TA indicator(s) are bullish.

  • TRAW’s TA Score: 3 bullish, 5 bearish.

Price Growth

TRAW (@Biotechnology) experienced а +8.99% price change this week, while VTVT (@Biotechnology) price change was +1.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.85%. For the same industry, the average monthly price growth was +10.46%, and the average quarterly price growth was -0.86%.

Reported Earning Dates

TRAW is expected to report earnings on Mar 31, 2025.

VTVT is expected to report earnings on May 15, 2025.

Industries' Descriptions

@Biotechnology (+7.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTVT($43.6M) has a higher market cap than TRAW($8.43M). VTVT YTD gains are higher at: 20.721 vs. TRAW (-82.939). VTVT has higher annual earnings (EBITDA): -22.51M vs. TRAW (-24.08M). VTVT has more cash in the bank: 41.6M vs. TRAW (5.41M). VTVT has higher revenues than TRAW: VTVT (1M) vs TRAW (226K).
TRAWVTVTTRAW / VTVT
Capitalization8.43M43.6M19%
EBITDA-24.08M-22.51M107%
Gain YTD-82.93920.721-400%
P/E RatioN/AN/A-
Revenue226K1M23%
Total Cash5.41M41.6M13%
Total DebtN/A213K-
FUNDAMENTALS RATINGS
TRAW vs VTVT: Fundamental Ratings
TRAW
VTVT
OUTLOOK RATING
1..100
3550
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
95
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6464
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TRAW's Valuation (31) in the Biotechnology industry is somewhat better than the same rating for VTVT (95). This means that TRAW’s stock grew somewhat faster than VTVT’s over the last 12 months.

TRAW's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as VTVT (100). This means that TRAW’s stock grew similarly to VTVT’s over the last 12 months.

TRAW's SMR Rating (100) in the Biotechnology industry is in the same range as VTVT (100). This means that TRAW’s stock grew similarly to VTVT’s over the last 12 months.

TRAW's Price Growth Rating (64) in the Biotechnology industry is in the same range as VTVT (64). This means that TRAW’s stock grew similarly to VTVT’s over the last 12 months.

TRAW's P/E Growth Rating (100) in the Biotechnology industry is in the same range as VTVT (100). This means that TRAW’s stock grew similarly to VTVT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TRAW
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 7 days ago
76%
Declines
ODDS (%)
Bearish Trend 16 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
TRAW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PBYI3.650.09
+2.53%
Puma Biotechnology
SNSE0.360.01
+2.53%
Sensei Biotherapeutics
HGTY10.030.04
+0.40%
Hagerty
FLEX42.56-0.21
-0.49%
Flex Ltd
ACVA16.31-0.11
-0.67%
ACV Auctions Inc